Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Antibodies, Viral"" wg kryterium: Temat


Tytuł:
Mosaic quadrivalent influenza vaccine single nanoparticle characterization.
Autorzy:
Yang RS; Vaccine Production Program, Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, 9 West Watkins Mill Rd., Gaithersburg, MD, 20878, USA.
Traver M; Twinbrook Imaging Facility, LIG, NIAID, NIH, Gaithersburg, MD, USA.
Barefoot N; Vaccine Production Program, Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, 9 West Watkins Mill Rd., Gaithersburg, MD, 20878, USA.
Stephens T; Vaccine Research Center Electron Microscopy Unit, Cancer Research Technology Program, Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research, Frederick, MD, USA.
Alabanza C; Vaccine Production Program, Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, 9 West Watkins Mill Rd., Gaithersburg, MD, 20878, USA.
Manzella-Lapeira J; Twinbrook Imaging Facility, LIG, NIAID, NIH, Gaithersburg, MD, USA.
Zou G; Vaccine Production Program, Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, 9 West Watkins Mill Rd., Gaithersburg, MD, 20878, USA.
Wolff J; Vaccine Production Program, Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, 9 West Watkins Mill Rd., Gaithersburg, MD, 20878, USA.
Li Y; Vaccine Production Program, Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, 9 West Watkins Mill Rd., Gaithersburg, MD, 20878, USA.
Resto M; Vaccine Production Program, Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, 9 West Watkins Mill Rd., Gaithersburg, MD, 20878, USA.
Shadrick W; Vaccine Production Program, Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, 9 West Watkins Mill Rd., Gaithersburg, MD, 20878, USA.
Yang Y; Vaccine Production Program, Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, 9 West Watkins Mill Rd., Gaithersburg, MD, 20878, USA.
Ivleva VB; Vaccine Production Program, Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, 9 West Watkins Mill Rd., Gaithersburg, MD, 20878, USA.
Tsybovsky Y; Vaccine Research Center Electron Microscopy Unit, Cancer Research Technology Program, Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research, Frederick, MD, USA.
Carlton K; Vaccine Production Program, Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, 9 West Watkins Mill Rd., Gaithersburg, MD, 20878, USA.
Brzostowski J; Twinbrook Imaging Facility, LIG, NIAID, NIH, Gaithersburg, MD, USA.
Gall JG; Vaccine Production Program, Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, 9 West Watkins Mill Rd., Gaithersburg, MD, 20878, USA.
Lei QP; Vaccine Production Program, Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, 9 West Watkins Mill Rd., Gaithersburg, MD, 20878, USA. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2024 Feb 24; Vol. 14 (1), pp. 4534. Date of Electronic Publication: 2024 Feb 24.
Typ publikacji:
Journal Article
MeSH Terms:
Influenza Vaccines*
Influenza, Human*/prevention & control
Nanoparticles*/chemistry
Humans ; Antibodies, Viral ; Hemagglutinin Glycoproteins, Influenza Virus ; Hemagglutinins ; Immunogenicity, Vaccine ; Clinical Trials as Topic
Czasopismo naukowe
Tytuł:
Immunogenicity and protective efficacy of a co-formulated two-in-one inactivated whole virus particle COVID-19/influenza vaccine.
Autorzy:
Handabile C; Institute for Vaccine Research and Development (HU-IVReD), Hokkaido University, Sapporo, Japan.; Division of Biologics Development, International Institute for Zoonosis Control, Hokkaido University, Sapporo, Japan.
Ohno M; Institute for Vaccine Research and Development (HU-IVReD), Hokkaido University, Sapporo, Japan.; Division of Biologics Development, International Institute for Zoonosis Control, Hokkaido University, Sapporo, Japan.; One Health Research Center, Hokkaido University, Sapporo, Japan.
Sekiya T; Institute for Vaccine Research and Development (HU-IVReD), Hokkaido University, Sapporo, Japan.; Division of Biologics Development, International Institute for Zoonosis Control, Hokkaido University, Sapporo, Japan.; International Collaboration Unit, International Institute for Zoonosis Control, Hokkaido University, Sapporo, Japan.; Department of Microbiology and Immunology, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Australia.
Nomura N; Institute for Vaccine Research and Development (HU-IVReD), Hokkaido University, Sapporo, Japan.; Division of Biologics Development, International Institute for Zoonosis Control, Hokkaido University, Sapporo, Japan.; Division of International Research Promotion, International Institute for Zoonosis Control, Hokkaido University, Sapporo, Japan.
Kawakita T; Institute for Vaccine Research and Development (HU-IVReD), Hokkaido University, Sapporo, Japan.; Division of Vaccine Immunology, International Institute for Zoonosis Control, Hokkaido University, Sapporo, Japan.
Kawahara M; Division of Biologics Development, International Institute for Zoonosis Control, Hokkaido University, Sapporo, Japan.
Endo M; KM Biologics Co. Ltd, Kumamoto, Japan.
Nishimura T; KM Biologics Co. Ltd, Kumamoto, Japan.
Okumura M; KM Biologics Co. Ltd, Kumamoto, Japan.
Toba S; Shionogi Pharmaceutical Research Center, Shionogi & Company, Limited, Toyonaka, Japan.; Division of Molecular Pathobiology, International Institute for Zoonosis Control, Hokkaido University, Sapporo, Japan.
Sasaki M; Institute for Vaccine Research and Development (HU-IVReD), Hokkaido University, Sapporo, Japan.; Division of Molecular Pathobiology, International Institute for Zoonosis Control, Hokkaido University, Sapporo, Japan.
Orba Y; Institute for Vaccine Research and Development (HU-IVReD), Hokkaido University, Sapporo, Japan.; Division of Molecular Pathobiology, International Institute for Zoonosis Control, Hokkaido University, Sapporo, Japan.
Chua BY; International Collaboration Unit, International Institute for Zoonosis Control, Hokkaido University, Sapporo, Japan.; Department of Microbiology and Immunology, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Australia.
Rowntree LC; Department of Microbiology and Immunology, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Australia.
Nguyen THO; Department of Microbiology and Immunology, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Australia.
Shingai M; Institute for Vaccine Research and Development (HU-IVReD), Hokkaido University, Sapporo, Japan.; Division of Biologics Development, International Institute for Zoonosis Control, Hokkaido University, Sapporo, Japan.; International Collaboration Unit, International Institute for Zoonosis Control, Hokkaido University, Sapporo, Japan.; Division of Vaccine Immunology, International Institute for Zoonosis Control, Hokkaido University, Sapporo, Japan.
Sato A; Institute for Vaccine Research and Development (HU-IVReD), Hokkaido University, Sapporo, Japan.; Shionogi Pharmaceutical Research Center, Shionogi & Company, Limited, Toyonaka, Japan.; Division of Molecular Pathobiology, International Institute for Zoonosis Control, Hokkaido University, Sapporo, Japan.
Sawa H; Institute for Vaccine Research and Development (HU-IVReD), Hokkaido University, Sapporo, Japan.; One Health Research Center, Hokkaido University, Sapporo, Japan.; International Collaboration Unit, International Institute for Zoonosis Control, Hokkaido University, Sapporo, Japan.; Division of Molecular Pathobiology, International Institute for Zoonosis Control, Hokkaido University, Sapporo, Japan.
Ogasawara K; Division of Biologics Development, International Institute for Zoonosis Control, Hokkaido University, Sapporo, Japan.
Kedzierska K; Institute for Vaccine Research and Development (HU-IVReD), Hokkaido University, Sapporo, Japan.; International Collaboration Unit, International Institute for Zoonosis Control, Hokkaido University, Sapporo, Japan.; Department of Microbiology and Immunology, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Australia.
Kida H; Institute for Vaccine Research and Development (HU-IVReD), Hokkaido University, Sapporo, Japan. .; Division of Biologics Development, International Institute for Zoonosis Control, Hokkaido University, Sapporo, Japan. .; International Collaboration Unit, International Institute for Zoonosis Control, Hokkaido University, Sapporo, Japan. .; Division of Vaccine Immunology, International Institute for Zoonosis Control, Hokkaido University, Sapporo, Japan. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2024 Feb 20; Vol. 14 (1), pp. 4204. Date of Electronic Publication: 2024 Feb 20.
Typ publikacji:
Journal Article
MeSH Terms:
Influenza, Human*
Influenza Vaccines*
Influenza A Virus, H1N1 Subtype*
COVID-19*/prevention & control
Animals ; Mice ; Humans ; COVID-19 Vaccines ; Antibodies, Viral ; SARS-CoV-2 ; Vaccination/methods ; Virion ; Immunogenicity, Vaccine
Czasopismo naukowe
Tytuł:
A pan-influenza monoclonal antibody neutralizes H5 strains and prophylactically protects through intranasal administration.
Autorzy:
Beukenhorst AL; Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, MA, USA. .; Leyden Laboratories BV, Leiden, The Netherlands. .; Centre for Epidemiology, University of Manchester, Manchester Academic Health Science Centre, Manchester, UK. .
Frallicciardi J; Leyden Laboratories BV, Leiden, The Netherlands.
Rice KL; Leyden Laboratories BV, Leiden, The Netherlands.
Koldijk MH; Leyden Laboratories BV, Leiden, The Netherlands.
Moreira de Mello JC; Leyden Laboratories BV, Leiden, The Netherlands.
Klap JM; Leyden Laboratories BV, Leiden, The Netherlands.
Hadjichrysanthou C; Department of Mathematics, University of Sussex, Brighton, UK.
Koch CM; Leyden Laboratories BV, Leiden, The Netherlands.
da Costa KAS; Viral Pseudotype Unit, Medway School of Pharmacy, University of Kent and University of Greenwich, Chatham, UK.
Temperton N; Viral Pseudotype Unit, Medway School of Pharmacy, University of Kent and University of Greenwich, Chatham, UK.
de Jong BA; Leyden Laboratories BV, Leiden, The Netherlands.
Vietsch H; Leyden Laboratories BV, Leiden, The Netherlands.
Ziere B; Leyden Laboratories BV, Leiden, The Netherlands.
Julg B; Leyden Laboratories BV, Leiden, The Netherlands.
Koudstaal W; Leyden Laboratories BV, Leiden, The Netherlands.
Goudsmit J; Leyden Laboratories BV, Leiden, The Netherlands.; Departments of Epidemiology, Immunology and Infectious Diseases, Harvard TH Chan School of Public Health, Boston, MA, USA.
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2024 Feb 15; Vol. 14 (1), pp. 3818. Date of Electronic Publication: 2024 Feb 15.
Typ publikacji:
Journal Article
MeSH Terms:
Influenza, Human*
Influenza Vaccines*
Influenza A Virus, H5N1 Subtype*
Humans ; Animals ; Mice ; Antibodies, Monoclonal ; Antibodies, Neutralizing ; Administration, Intranasal ; Antibodies, Viral ; Epitopes ; Hemagglutinin Glycoproteins, Influenza Virus ; Mice, Inbred BALB C
Czasopismo naukowe
Tytuł:
Polysaccharide from Atractylodes macrocephala Koidz Binding with Zinc Oxide Nanoparticles as a Novel Mucosal Immune Adjuvant for H9N2 Inactivated Vaccine.
Autorzy:
Liu X; College of Veterinary Medicine, Jiangsu Co-Innovation Center for Prevention and Control of Important Animal Infectious Diseases and Zoonoses, Yangzhou University, Yangzhou 225009, China.
Lin X; College of Veterinary Medicine, Jiangsu Co-Innovation Center for Prevention and Control of Important Animal Infectious Diseases and Zoonoses, Yangzhou University, Yangzhou 225009, China.
Hong H; College of Veterinary Medicine, Jiangsu Co-Innovation Center for Prevention and Control of Important Animal Infectious Diseases and Zoonoses, Yangzhou University, Yangzhou 225009, China.
Wang J; College of Veterinary Medicine, Jiangsu Co-Innovation Center for Prevention and Control of Important Animal Infectious Diseases and Zoonoses, Yangzhou University, Yangzhou 225009, China.
Tao Y; College of Veterinary Medicine, Jiangsu Co-Innovation Center for Prevention and Control of Important Animal Infectious Diseases and Zoonoses, Yangzhou University, Yangzhou 225009, China.
Huai Y; College of Veterinary Medicine, Jiangsu Co-Innovation Center for Prevention and Control of Important Animal Infectious Diseases and Zoonoses, Yangzhou University, Yangzhou 225009, China.; Joint International Research Laboratory of Agriculture and Agri-Product Safety, The Ministry of Education of China, Yangzhou University, Yangzhou 225009, China.
Pang H; School of Chemistry and Chemical Engineering, Yangzhou University, Yangzhou 225009, China.
Liu M; College of Veterinary Medicine, Jiangsu Co-Innovation Center for Prevention and Control of Important Animal Infectious Diseases and Zoonoses, Yangzhou University, Yangzhou 225009, China.; Joint International Research Laboratory of Agriculture and Agri-Product Safety, The Ministry of Education of China, Yangzhou University, Yangzhou 225009, China.
Li J; College of Veterinary Medicine, Jiangsu Co-Innovation Center for Prevention and Control of Important Animal Infectious Diseases and Zoonoses, Yangzhou University, Yangzhou 225009, China.; Joint International Research Laboratory of Agriculture and Agri-Product Safety, The Ministry of Education of China, Yangzhou University, Yangzhou 225009, China.
Bo R; College of Veterinary Medicine, Jiangsu Co-Innovation Center for Prevention and Control of Important Animal Infectious Diseases and Zoonoses, Yangzhou University, Yangzhou 225009, China.; Joint International Research Laboratory of Agriculture and Agri-Product Safety, The Ministry of Education of China, Yangzhou University, Yangzhou 225009, China.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2024 Feb 09; Vol. 25 (4). Date of Electronic Publication: 2024 Feb 09.
Typ publikacji:
Journal Article
MeSH Terms:
Influenza A Virus, H9N2 Subtype*
Atractylodes*
Zinc Oxide*
Influenza Vaccines*
Animals ; Mice ; Adjuvants, Immunologic/pharmacology ; Immunity, Mucosal ; Vaccines, Inactivated ; Polysaccharides/pharmacology ; Antibodies, Viral
Czasopismo naukowe
Tytuł:
Pre-vaccination immunotypes reveal weak and robust antibody responders to influenza vaccination.
Autorzy:
Cevirgel A; Center for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, The Netherlands.; Department of Medical Microbiology and Infection Prevention, Virology and Immunology research group, University Medical Center Groningen, Groningen, The Netherlands.
Shetty SA; Center for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, The Netherlands.; Department of Medical Microbiology and Infection Prevention, Virology and Immunology research group, University Medical Center Groningen, Groningen, The Netherlands.
Vos M; Center for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, The Netherlands.
Nanlohy NM; Center for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, The Netherlands.
Beckers L; Center for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, The Netherlands.
Bijvank E; Center for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, The Netherlands.
Rots N; Center for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, The Netherlands.
van Beek J; Center for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, The Netherlands.
Buisman AM; Center for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, The Netherlands.
van Baarle D; Center for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, The Netherlands.; Department of Medical Microbiology and Infection Prevention, Virology and Immunology research group, University Medical Center Groningen, Groningen, The Netherlands.
Pokaż więcej
Źródło:
Aging cell [Aging Cell] 2024 Feb; Vol. 23 (2), pp. e14048. Date of Electronic Publication: 2023 Dec 25.
Typ publikacji:
Journal Article
MeSH Terms:
Influenza, Human*/prevention & control
Influenza Vaccines*
Humans ; Aged ; T-Lymphocytes ; Antibodies, Viral ; Vaccination
Czasopismo naukowe
Tytuł:
The Chinese Hamster Ovary Cell-Based H9 HA Subunit Avian Influenza Vaccine Provides Complete Protection against the H9N2 Virus Challenge in Chickens.
Autorzy:
Zhu S; Department of Biopharmacy, College of Life Sciences and Medicine, Zhejiang Sci-Tech University, Hangzhou 310018, China.
Nie Z; Department of Biopharmacy, College of Life Sciences and Medicine, Zhejiang Sci-Tech University, Hangzhou 310018, China.
Che Y; Zhejiang Novo Biotech Co., Ltd., Shaoxing 312366, China.
Shu J; Department of Biopharmacy, College of Life Sciences and Medicine, Zhejiang Sci-Tech University, Hangzhou 310018, China.
Wu S; Zhejiang Novo Biotech Co., Ltd., Shaoxing 312366, China.
He Y; Department of Biopharmacy, College of Life Sciences and Medicine, Zhejiang Sci-Tech University, Hangzhou 310018, China.
Wu Y; Zhejiang Novo Biotech Co., Ltd., Shaoxing 312366, China.
Qian H; Zhejiang Novo Biotech Co., Ltd., Shaoxing 312366, China.
Feng H; Department of Biopharmacy, College of Life Sciences and Medicine, Zhejiang Sci-Tech University, Hangzhou 310018, China.
Zhang Q; Zhejiang Novo Biotech Co., Ltd., Shaoxing 312366, China.
Pokaż więcej
Źródło:
Viruses [Viruses] 2024 Jan 22; Vol. 16 (1). Date of Electronic Publication: 2024 Jan 22.
Typ publikacji:
Journal Article
MeSH Terms:
Influenza in Birds*
Influenza A Virus, H9N2 Subtype*/genetics
Influenza Vaccines*
Animals ; Humans ; Cricetinae ; Chickens ; Hemagglutinins ; Cricetulus ; CHO Cells ; Antibodies, Viral ; Vaccines, Subunit ; Hemagglutinin Glycoproteins, Influenza Virus/genetics
Czasopismo naukowe
Tytuł:
Longitudinal analysis of influenza vaccination implicates regulation of RIG-I signaling by DNA methylation.
Autorzy:
Fu H; Department of Molecular Cell and Developmental Biology, University of California Los Angeles, Los Angeles, CA, USA.
Pickering H; Department of Pathology and Laboratory Medicine, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, USA.
Rubbi L; Department of Molecular Cell and Developmental Biology, University of California Los Angeles, Los Angeles, CA, USA.
Ross TM; Department of Infectious Diseases, University of Georgia, Athens, GA, USA.; Center for Vaccines and Immunology, University of Georgia, Athens, GA, USA.
Reed EF; Department of Pathology and Laboratory Medicine, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, USA.
Pellegrini M; Department of Molecular Cell and Developmental Biology, University of California Los Angeles, Los Angeles, CA, USA. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2024 Jan 17; Vol. 14 (1), pp. 1455. Date of Electronic Publication: 2024 Jan 17.
Typ publikacji:
Journal Article
MeSH Terms:
Influenza, Human*/prevention & control
Influenza Vaccines*
Humans ; DNA Methylation ; Leukocytes, Mononuclear ; Vaccination/methods ; DEAD Box Protein 58/genetics ; Signal Transduction ; Antibodies, Viral
Czasopismo naukowe
Tytuł:
Multivalent next generation influenza virus vaccines protect against seasonal and pre-pandemic viruses.
Autorzy:
Uno N; Center for Vaccines and Immunology, University of Georgia, Athens, GA, USA.; Department of Infection Biology, Lerner Research Institute, Cleveland Clinic, Cleveland, OH, USA.
Ross TM; Center for Vaccines and Immunology, University of Georgia, Athens, GA, USA. .; Department of Infectious Diseases, University of Georgia, Athens, GA, USA. .; Florida Research and Innovation Center, Cleveland Clinic Florida, 9801 SW Discovery Way, Port Saint Lucie, FL, 34986, USA. .; Department of Infection Biology, Lerner Research Institute, Cleveland Clinic, Cleveland, OH, USA. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2024 Jan 16; Vol. 14 (1), pp. 1440. Date of Electronic Publication: 2024 Jan 16.
Typ publikacji:
Journal Article
MeSH Terms:
Influenza Vaccines*
Orthomyxoviridae Infections*
Influenza, Human*
Influenza A Virus, H1N1 Subtype*
Animals ; Mice ; Humans ; Seasons ; Pandemics ; Antibodies, Viral ; Antigens, Viral ; Hemagglutinin Glycoproteins, Influenza Virus
Czasopismo naukowe
Tytuł:
Avian Influenza A(H5N1) Neuraminidase Inhibition Antibodies in Healthy Adults after Exposure to Influenza A(H1N1)pdm09.
Autorzy:
Daulagala P
Cheng SMS
Chin A
Luk LLH
Leung K
Wu JT
Poon LLM
Peiris M
Yen HL
Pokaż więcej
Źródło:
Emerging infectious diseases [Emerg Infect Dis] 2024 Jan; Vol. 30 (1), pp. 168-171.
Typ publikacji:
Journal Article
MeSH Terms:
Influenza, Human*
Influenza A Virus, H5N1 Subtype*
Influenza A Virus, H1N1 Subtype*
Influenza in Birds*
Influenza Vaccines*
Adult ; Animals ; Humans ; Neuraminidase ; Antibodies, Viral
Czasopismo naukowe
Tytuł:
A new class of antibodies that overcomes a steric barrier to cross-group neutralization of influenza viruses.
Autorzy:
Simmons HC; Center for Vaccine Research, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, United States of America.; Department of Microbiology and Molecular Genetics, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, United States of America.
Watanabe A; Department of Integrative Immunobiology, Duke University, Durham, North Carolina, United States of America.
Oguin Iii TH; Duke Human Vaccine Institute, Duke University, Durham, North Carolina, United States of America.
Van Itallie ES; Duke Human Vaccine Institute, Duke University, Durham, North Carolina, United States of America.
Wiehe KJ; Duke Human Vaccine Institute, Duke University, Durham, North Carolina, United States of America.
Sempowski GD; Duke Human Vaccine Institute, Duke University, Durham, North Carolina, United States of America.
Kuraoka M; Department of Integrative Immunobiology, Duke University, Durham, North Carolina, United States of America.
Kelsoe G; Department of Integrative Immunobiology, Duke University, Durham, North Carolina, United States of America.; Duke Human Vaccine Institute, Duke University, Durham, North Carolina, United States of America.
McCarthy KR; Center for Vaccine Research, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, United States of America.; Department of Microbiology and Molecular Genetics, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, United States of America.
Pokaż więcej
Źródło:
PLoS biology [PLoS Biol] 2023 Dec 21; Vol. 21 (12), pp. e3002415. Date of Electronic Publication: 2023 Dec 21 (Print Publication: 2023).
Typ publikacji:
Journal Article
MeSH Terms:
Influenza Vaccines*
Influenza, Human*
Humans ; Antibodies, Viral ; Hemagglutinin Glycoproteins, Influenza Virus/chemistry ; Influenza A Virus, H3N2 Subtype ; Binding Sites
Czasopismo naukowe
Tytuł:
Systematic Review of Equine Influenza A Virus Vaccine Studies and Meta-Analysis of Vaccine Efficacy.
Autorzy:
Elliott S; One Virology, Wolfson Centre for Global Virus Research, School of Veterinary Medicine and Science, University of Nottingham, Sutton Bonington LE12 5RD, UK.
Olufemi OT; One Virology, Wolfson Centre for Global Virus Research, School of Veterinary Medicine and Science, University of Nottingham, Sutton Bonington LE12 5RD, UK.
Daly JM; One Virology, Wolfson Centre for Global Virus Research, School of Veterinary Medicine and Science, University of Nottingham, Sutton Bonington LE12 5RD, UK.
Pokaż więcej
Źródło:
Viruses [Viruses] 2023 Nov 28; Vol. 15 (12). Date of Electronic Publication: 2023 Nov 28.
Typ publikacji:
Systematic Review; Meta-Analysis; Journal Article; Review
MeSH Terms:
Influenza Vaccines*
Influenza A Virus, H3N8 Subtype*
Horse Diseases*/epidemiology
Influenza A virus*
Orthomyxoviridae Infections*/prevention & control
Orthomyxoviridae Infections*/veterinary
Animals ; Horses ; Female ; Chickens ; Vaccine Efficacy ; Antibodies, Viral ; Vaccination/veterinary
Czasopismo naukowe
Tytuł:
Assessment of Equine Influenza Virus Status in the Republic of Korea from 2020 to 2022.
Autorzy:
Lim SI; Viral Disease Division, Animal and Plant Quarantine Agency, Gimcheon 39660, Republic of Korea.
Kim MJ; Viral Disease Division, Animal and Plant Quarantine Agency, Gimcheon 39660, Republic of Korea.
Kim MJ; Viral Disease Division, Animal and Plant Quarantine Agency, Gimcheon 39660, Republic of Korea.
Lee SK; Veterinary Center, Korea Racing Authority, Gwacheon 13822, Republic of Korea.
Yang HS; Animal Health Diagnosis Division, Jeju Self-Governing Provincial Veterinary Research Institute, Jeju 63344, Republic of Korea.
Kwon M; Viral Disease Division, Animal and Plant Quarantine Agency, Gimcheon 39660, Republic of Korea.
Lim EH; Viral Disease Division, Animal and Plant Quarantine Agency, Gimcheon 39660, Republic of Korea.
Ouh IO; Division of Vaccine Development Coordination, National Institute of Infectious Disease, Cheongju 28160, Republic of Korea.
Kim EJ; Viral Disease Division, Animal and Plant Quarantine Agency, Gimcheon 39660, Republic of Korea.
Hyun BH; Viral Disease Division, Animal and Plant Quarantine Agency, Gimcheon 39660, Republic of Korea.
Lee YH; Viral Disease Division, Animal and Plant Quarantine Agency, Gimcheon 39660, Republic of Korea.
Pokaż więcej
Źródło:
Viruses [Viruses] 2023 Oct 23; Vol. 15 (10). Date of Electronic Publication: 2023 Oct 23.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Orthomyxoviridae Infections*/epidemiology
Orthomyxoviridae Infections*/veterinary
Influenza A Virus, H3N8 Subtype*
Influenza Vaccines*
Horse Diseases*
Animals ; Horses ; Republic of Korea/epidemiology ; Vaccination/veterinary ; Antibodies, Viral
Czasopismo naukowe
Tytuł:
Sex-Specific Immune Responses to Seasonal Influenza Vaccination in Diabetic Individuals: Implications for Vaccine Efficacy.
Autorzy:
Sengupta A; Department of Biomedical and Clinical Sciences, Linköping University, Linköping 58185, Sweden.
Al-Otaibi N; King Abdulaziz City for Science and Technology (KACST), Riyad 11442, Saudi Arabia.
Hinkula J; Department of Biomedical and Clinical Sciences, Linköping University, Linköping 58185, Sweden.
Pokaż więcej
Źródło:
Journal of immunology research [J Immunol Res] 2023 Oct 17; Vol. 2023, pp. 3111351. Date of Electronic Publication: 2023 Oct 17 (Print Publication: 2023).
Typ publikacji:
Journal Article
MeSH Terms:
Influenza, Human*/prevention & control
Influenza Vaccines*
Diabetes Mellitus*
Male ; Female ; Humans ; Vaccine Efficacy ; Seasons ; Vaccination ; Immunity, Humoral ; Antibodies, Viral
Czasopismo naukowe
Tytuł:
A computationally optimized broadly reactive hemagglutinin vaccine elicits neutralizing antibodies against influenza B viruses from both lineages.
Autorzy:
Carlock MA; Center for Vaccines and Immunology, University of Georgia, Athens, GA, USA.; Global Vaccine Development, Florida Research and Innovation Center, Cleveland Clinic, Port Saint Lucie, FL, USA.
Ross TM; Center for Vaccines and Immunology, University of Georgia, Athens, GA, USA. .; Department of Infectious Diseases, University of Georgia, Athens, GA, USA. .; Global Vaccine Development, Florida Research and Innovation Center, Cleveland Clinic, Port Saint Lucie, FL, USA. .; Department of Infection Biology, Lehner Research Institute, Cleveland Clinic, Cleveland, OH, USA. .; Global Vaccine Development, Florida Research and Innovation Center, Cleveland Clinic, 9801 SW Discovery Way, Port Saint Lucie, FL, 34987, USA. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2023 Sep 23; Vol. 13 (1), pp. 15911. Date of Electronic Publication: 2023 Sep 23.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural
MeSH Terms:
Orthomyxoviridae Infections*
Influenza Vaccines*
Influenza, Human*
Child ; Animals ; Humans ; Influenza B virus ; Hemagglutinins ; Antibodies, Neutralizing ; Ferrets ; Antibodies, Viral ; Hemagglutinin Glycoproteins, Influenza Virus ; Antigens, Viral
Czasopismo naukowe
Tytuł:
Adjuvant effects of combination monophosphoryl lipid A and poly I:C on antigen-specific immune responses and protective efficacy of influenza vaccines.
Autorzy:
Le CTT; Interdisciplinary Graduate Program in Advanced Convergence Technology and Science, Jeju National University, Jeju, 63243, Republic of Korea.; Center for Inflammation, Immunity and Infection, Institute for Biomedical Sciences, Georgia State University, Atlanta, GA, 30303, USA.
Ahn SY; College of Veterinary Medicine and Veterinary Medical Research Institute, Jeju National University, Jeju, 63243, Republic of Korea.
Ho TL; Interdisciplinary Graduate Program in Advanced Convergence Technology and Science, Jeju National University, Jeju, 63243, Republic of Korea.
Lee J; College of Veterinary Medicine and Veterinary Medical Research Institute, Jeju National University, Jeju, 63243, Republic of Korea.
Lee DH; College of Veterinary Medicine and Veterinary Medical Research Institute, Jeju National University, Jeju, 63243, Republic of Korea.
Hwang HS; Department of Biomedical Science, College of Life Science and Industry, Sunchon National University, Suncheon, 57922, Republic of Korea. .
Kang SM; Center for Inflammation, Immunity and Infection, Institute for Biomedical Sciences, Georgia State University, Atlanta, GA, 30303, USA. .
Ko EJ; Interdisciplinary Graduate Program in Advanced Convergence Technology and Science, Jeju National University, Jeju, 63243, Republic of Korea. .; College of Veterinary Medicine and Veterinary Medical Research Institute, Jeju National University, Jeju, 63243, Republic of Korea. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2023 Jul 28; Vol. 13 (1), pp. 12231. Date of Electronic Publication: 2023 Jul 28.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:
Influenza Vaccines*
Influenza, Human*
Influenza A Virus, H1N1 Subtype*
Animals ; Mice ; Humans ; Poly I-C/pharmacology ; Antibodies, Viral ; Adjuvants, Immunologic/pharmacology ; Immunity ; Adjuvants, Pharmaceutic ; Mice, Inbred BALB C
Czasopismo naukowe
Tytuł:
A structure and knowledge-based combinatorial approach to engineering universal scFv antibodies against influenza M2 protein.
Autorzy:
Kumar U; International Centre for Genetic Engineering and Biotechnology, Aruna Asaf Ali Marg, New Delhi, 110067, India.
Goyal P; Jawaharlal Nehru University, New Delhi, Delhi, 110067, India.
Madni ZK; International Centre for Genetic Engineering and Biotechnology, Aruna Asaf Ali Marg, New Delhi, 110067, India.
Kamble K; National Institute of Immunology, Aruna Asaf Ali Marg, New Delhi, 110067, India.
Gaur V; National Institute of Plant Genome Research, Aruna Asaf Ali Marg, New Delhi, 110067, India.
Rajala MS; Jawaharlal Nehru University, New Delhi, Delhi, 110067, India.
Salunke DM; International Centre for Genetic Engineering and Biotechnology, Aruna Asaf Ali Marg, New Delhi, 110067, India. .
Pokaż więcej
Źródło:
Journal of biomedical science [J Biomed Sci] 2023 Jul 25; Vol. 30 (1), pp. 56. Date of Electronic Publication: 2023 Jul 25.
Typ publikacji:
Journal Article
MeSH Terms:
Influenza A Virus, H1N1 Subtype*
Influenza Vaccines*
Influenza, Human*
Single-Chain Antibodies*/genetics
Single-Chain Antibodies*/metabolism
Humans ; Antibodies, Monoclonal/genetics ; Antibodies, Monoclonal/metabolism ; Antibodies, Viral ; HEK293 Cells
Czasopismo naukowe
Tytuł:
IgGκ Signal Peptide Enhances the Efficacy of an Influenza Vector Vaccine against Respiratory Syncytial Virus Infection in Mice.
Autorzy:
Pulkina A; Smorodintsev Research Institute of Influenza of the Ministry of Health of the Russian Federation, 197022 St. Petersburg, Russia.
Vasilyev K; Smorodintsev Research Institute of Influenza of the Ministry of Health of the Russian Federation, 197022 St. Petersburg, Russia.
Muzhikyan A; Smorodintsev Research Institute of Influenza of the Ministry of Health of the Russian Federation, 197022 St. Petersburg, Russia.
Sergeeva M; Smorodintsev Research Institute of Influenza of the Ministry of Health of the Russian Federation, 197022 St. Petersburg, Russia.
Romanovskaya-Romanko E; Smorodintsev Research Institute of Influenza of the Ministry of Health of the Russian Federation, 197022 St. Petersburg, Russia.
Shurygina AP; Smorodintsev Research Institute of Influenza of the Ministry of Health of the Russian Federation, 197022 St. Petersburg, Russia.
Shuklina M; Smorodintsev Research Institute of Influenza of the Ministry of Health of the Russian Federation, 197022 St. Petersburg, Russia.
Vasin A; Smorodintsev Research Institute of Influenza of the Ministry of Health of the Russian Federation, 197022 St. Petersburg, Russia.
Stukova M; Smorodintsev Research Institute of Influenza of the Ministry of Health of the Russian Federation, 197022 St. Petersburg, Russia.
Egorov A; Smorodintsev Research Institute of Influenza of the Ministry of Health of the Russian Federation, 197022 St. Petersburg, Russia.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2023 Jul 14; Vol. 24 (14). Date of Electronic Publication: 2023 Jul 14.
Typ publikacji:
Journal Article
MeSH Terms:
Respiratory Syncytial Virus Infections*
Influenza Vaccines*
Influenza, Human*
Respiratory Syncytial Virus, Human*/genetics
Respiratory Syncytial Virus Vaccines*
Animals ; Mice ; Humans ; Antibodies, Viral ; Mice, Inbred BALB C
Czasopismo naukowe
Tytuł:
Fc-Effector-Independent in vivo Activity of a Potent Influenza B Neuraminidase Broadly Neutralizing Antibody.
Autorzy:
Khalil AM; Texas Biomedical Research Institute, San Antonio, TX 78245, USA.; Department of Zoonotic Diseases, Faculty of Veterinary Medicine, Zagazig University, Zagazig 44511, Egypt.
Piepenbrink MS; Division of Infectious Diseases, University of Alabama at Birmingham, Birmingham, AL 35294, USA.
Markham I; Division of Infectious Diseases, University of Alabama at Birmingham, Birmingham, AL 35294, USA.
Basu M; Division of Infectious Diseases, University of Alabama at Birmingham, Birmingham, AL 35294, USA.
Martinez-Sobrido L; Texas Biomedical Research Institute, San Antonio, TX 78245, USA.
Kobie JJ; Division of Infectious Diseases, University of Alabama at Birmingham, Birmingham, AL 35294, USA.
Pokaż więcej
Źródło:
Viruses [Viruses] 2023 Jul 13; Vol. 15 (7). Date of Electronic Publication: 2023 Jul 13.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural
MeSH Terms:
Influenza, Human*
Influenza A virus*
Influenza Vaccines*
Orthomyxoviridae Infections*
Child ; Animals ; Mice ; Humans ; Broadly Neutralizing Antibodies ; Neuraminidase ; Antibodies, Viral ; Influenza B virus ; Antibodies, Monoclonal/pharmacology ; Receptors, Fc ; Hemagglutinin Glycoproteins, Influenza Virus
Czasopismo naukowe
Tytuł:
The impact of pre-existing influenza antibodies and inflammatory status on the influenza vaccine responses in older adults.
Autorzy:
Kang M; School of Public Health Southern Medical University Guangzhou P. R. China.; Guangdong Center for Disease Control and Prevention Guangzhou P. R. China.
Lin F; Guangzhou Medical University, Xinzao Guangzhou P. R. China.; State Key Laboratory for Respiratory Diseases and National Clinical Research Centre for Respiratory Disease Guangzhou P.R. China.
Jiang Z; Guangzhou Medical University, Xinzao Guangzhou P. R. China.; State Key Laboratory for Respiratory Diseases and National Clinical Research Centre for Respiratory Disease Guangzhou P.R. China.
Tan X; Guangdong Center for Disease Control and Prevention Guangzhou P. R. China.
Lin X; Guangzhou Medical University, Xinzao Guangzhou P. R. China.; State Key Laboratory for Respiratory Diseases and National Clinical Research Centre for Respiratory Disease Guangzhou P.R. China.
Liang Z; Guangzhou Medical University, Xinzao Guangzhou P. R. China.; State Key Laboratory for Respiratory Diseases and National Clinical Research Centre for Respiratory Disease Guangzhou P.R. China.; HKU-Pasteur Research Pole, School of Public Health, LKS Faculty of Medicine The University of Hong Kong Hong Kong China.
Xiao C; Guangzhou Medical University, Xinzao Guangzhou P. R. China.; State Key Laboratory for Respiratory Diseases and National Clinical Research Centre for Respiratory Disease Guangzhou P.R. China.; HKU-Pasteur Research Pole, School of Public Health, LKS Faculty of Medicine The University of Hong Kong Hong Kong China.
Xia Y; Zhongshan Yiyan Bio-Pharmaceutical Co., Ltd Zhongshan P. R. China.
Guan W; State Key Laboratory for Respiratory Diseases and National Clinical Research Centre for Respiratory Disease Guangzhou P.R. China.; Guangzhou Institute of Respiratory Health First Affiliated Hospital of Guangzhou Medical University, National Center for Respiratory Medicine Guangzhou P.R. China.
Yang Z; State Key Laboratory for Respiratory Diseases and National Clinical Research Centre for Respiratory Disease Guangzhou P.R. China.; Guangzhou Institute of Respiratory Health First Affiliated Hospital of Guangzhou Medical University, National Center for Respiratory Medicine Guangzhou P.R. China.
Yu G; Department of Bioinformatics, School of Basic Medical Sciences Southern Medical University Guangzhou P. R. China.
Zanin M; School of Public Health, LKS Faculty of Medicine The University of Hong Kong Hong Kong China.; Centre for Immunology & Infection Shatin Hong Kong.
Tang S; School of Public Health Southern Medical University Guangzhou P. R. China.
Wong SS; HKU-Pasteur Research Pole, School of Public Health, LKS Faculty of Medicine The University of Hong Kong Hong Kong China.; School of Public Health, LKS Faculty of Medicine The University of Hong Kong Hong Kong China.
Pokaż więcej
Źródło:
Influenza and other respiratory viruses [Influenza Other Respir Viruses] 2023 Jul 12; Vol. 17 (7), pp. e13172. Date of Electronic Publication: 2023 Jul 12 (Print Publication: 2023).
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Influenza Vaccines*
Influenza, Human*/prevention & control
Humans ; Aged ; Interleukin-10 ; Tumor Necrosis Factor-alpha ; Antibodies, Viral ; Immunoglobulin G
Czasopismo naukowe
Tytuł:
Vaccine-Induced Immunity Elicited by Microneedle Delivery of Influenza Ectodomain Matrix Protein 2 Virus-like Particle (M2e VLP)-Loaded PLGA Nanoparticles.
Autorzy:
Braz Gomes K; Center for Drug Delivery and Research, Vaccine Nanotechnology Laboratory, College of Pharmacy, Mercer University, Atlanta, GA 30341, USA.
Vijayanand S; Center for Drug Delivery and Research, Vaccine Nanotechnology Laboratory, College of Pharmacy, Mercer University, Atlanta, GA 30341, USA.
Bagwe P; Center for Drug Delivery and Research, Vaccine Nanotechnology Laboratory, College of Pharmacy, Mercer University, Atlanta, GA 30341, USA.
Menon I; Center for Drug Delivery and Research, Vaccine Nanotechnology Laboratory, College of Pharmacy, Mercer University, Atlanta, GA 30341, USA.
Kale A; Center for Drug Delivery and Research, Vaccine Nanotechnology Laboratory, College of Pharmacy, Mercer University, Atlanta, GA 30341, USA.
Patil S; Center for Drug Delivery and Research, Vaccine Nanotechnology Laboratory, College of Pharmacy, Mercer University, Atlanta, GA 30341, USA.
Kang SM; Center for Inflammation, Immunity, and Infection, Institute for Biomedical Sciences, Georgia State University, Atlanta, GA 30303, USA.
Uddin MN; Center for Drug Delivery and Research, Vaccine Nanotechnology Laboratory, College of Pharmacy, Mercer University, Atlanta, GA 30341, USA.
D'Souza MJ; Center for Drug Delivery and Research, Vaccine Nanotechnology Laboratory, College of Pharmacy, Mercer University, Atlanta, GA 30341, USA.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2023 Jun 25; Vol. 24 (13). Date of Electronic Publication: 2023 Jun 25.
Typ publikacji:
Journal Article
MeSH Terms:
Influenza, Human*/prevention & control
Influenza Vaccines*
Nanoparticles*/chemistry
Mice ; Animals ; Humans ; Antigens ; Adjuvants, Immunologic/pharmacology ; Mice, Inbred BALB C ; Antibodies, Viral
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies